Pharmaceutical giant Moderna has commenced a clinical trial to evaluate its COVID-19 vaccine in children under the age of 12, including infants as young as six months. The study aims to enroll approximately 6,750 healthy children across the United States and Canada. Dr. Samuel Bright, a pediatric vaccine specialist, remarked to the New York Times, “There’s a significant interest in understanding how vaccination will benefit children.”
Participants in the trial will receive two doses of the vaccine, spaced 28 days apart. For children aged two to twelve, doses may include either 50 or 100 micrograms, while those under two could receive doses of 25, 50, or 100 micrograms. This initiative is particularly encouraging for parents eager to protect their children through vaccination, especially as many adults have already been vaccinated. Experts like Dr. Emily Carter stress the importance of vaccinating children in achieving herd immunity, a sentiment echoed by the American Academy of Pediatrics, which advocates for expanded vaccine trials for younger age groups.
In a related effort, Moderna is conducting another study involving 3,000 adolescents aged 12 to 17, with results expected by summer. If deemed safe and effective, the vaccine will need to be authorized for children’s use before distribution.
The administration of the vaccine will begin with the lowest doses for the first participants, who will be closely monitored for any adverse reactions before escalating to higher doses. Following vaccination, participants will be observed for a year to monitor side effects and measure antibody levels, which will help determine the vaccine’s protective effectiveness.
Current projections suggest that older children may be vaccinated as early as this fall, while younger children might have to wait until late 2021 or early 2022. The launch of this pediatric study coincides with the one-year anniversary of the first adult receiving the Moderna vaccine in initial trials last March.
If you’re interested in learning more about home insemination, check out this helpful resource. For those seeking authoritative information on artificial insemination, Make A Mom is a great platform. Additionally, ACOG provides excellent guidance on treating infertility.
Search Queries:
- home insemination kit
- home insemination syringe
- self insemination
- how to inseminate at home
- DIY insemination methods
In summary, Moderna’s new trial for its COVID vaccine in infants and young children marks a significant step towards understanding the role of vaccination in protecting younger populations. As researchers work diligently to ensure safety and efficacy, parents can look forward to the possibility of immunizing their children against COVID-19 in the near future.
Leave a Reply